Literature DB >> 1526243

Pulmonary abscess due to a rifampin and fluoroquinolone resistant Rhodococcus equi strain in a HIV infected patient.

P Nordmann, E Rouveix, M Guenounou, M H Nicolas.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1526243     DOI： 10.1007/bf01960815

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN： 0934-9723            Impact factor:   3.267


× No keyword cloud information.
  7 in total

1.  Imipenem/vancomycin for Rhodococcus equi pulmonary infection in HIV-positive patient.

Authors:  R M Rouquet; D Clave; P Massip; N Moatti; P Leophonte
Journal:  Lancet       Date:  1991-02-09       Impact factor: 79.321

2.  Imipenem/teicoplanin for Rhodococcus equi pulmonary infection in AIDS patients.

Authors:  P Chavanet; B Bonnotte; D Caillot; H Portier
Journal:  Lancet       Date:  1991-03-30       Impact factor: 79.321

3.  Use of erythromycin-rifampin combination in treatment of Rhodococcus equi pneumonia.

Authors:  C J Hillidge
Journal:  Vet Microbiol       Date:  1987-08       Impact factor: 3.293

4.  Corynebacterium equi: in vitro susceptibility to twenty-six antimicrobial agents.

Authors:  J B Woolcock; M D Mutimer
Journal:  Antimicrob Agents Chemother       Date:  1980-12       Impact factor: 5.191

Review 5.  Rhodococcus equi infection in patients with and without human immunodeficiency virus infection.

Authors:  R L Harvey; J C Sunstrum
Journal:  Rev Infect Dis       Date:  1991 Jan-Feb

6.  Lung abscess due to Corynebacterium equi. Report of first human infection.

Authors:  B Golub; G Falk; W W Spink
Journal:  Ann Intern Med       Date:  1967-06       Impact factor: 25.391

Review 7.  Rhodococcus equi: an animal and human pathogen.

Authors:  J F Prescott
Journal:  Clin Microbiol Rev       Date:  1991-01       Impact factor: 26.132
  7 in total
  7 in total

1.  Emergence of rifampin-resistant Rhodococcus equi in an infected foal.

Authors:  S Takai; K Takeda; Y Nakano; T Karasawa; J Furugoori; Y Sasaki; S Tsubaki; T Higuchi; T Anzai; R Wada; M Kamada
Journal:  J Clin Microbiol       Date:  1997-07       Impact factor: 5.948

2.  Mutant selection window and characterization of allelic diversity for ciprofloxacin-resistant mutants of Rhodococcus equi.

Authors:  Hidekazu Niwa; Brent A Lasker
Journal:  Antimicrob Agents Chemother       Date:  2010-05-24       Impact factor: 5.191

3.  Failure of pulmonary clearance of Rhodococcus equi infection in CD4+ T-lymphocyte-deficient transgenic mice.

Authors:  S T Kanaly; S A Hines; G H Palmer
Journal:  Infect Immun       Date:  1993-11       Impact factor: 3.441

4.  Correlation between antibiotic resistance, phage-like particle presence, and virulence in Rhodococcus equi human isolates.

Authors:  P Nordmann; M Keller; F Espinasse; E Ronco
Journal:  J Clin Microbiol       Date:  1994-02       Impact factor: 5.948

5.  Transfer of a CD4+ Th1 cell line to nude mice effects clearance of Rhodococcus equi from the lung.

Authors:  S T Kanaly; S A Hines; G H Palmer
Journal:  Infect Immun       Date:  1996-04       Impact factor: 3.441

6.  Pathogenic Nocardia, Rhodococcus, and related organisms are highly susceptible to imidazole antifungals.

Authors:  Eric R Dabbs; Samantha Naidoo; Catherine Lephoto; Natalya Nikitina
Journal:  Antimicrob Agents Chemother       Date:  2003-04       Impact factor: 5.191

7.  Antimicrobial Resistance Spectrum Conferred by pRErm46 of Emerging Macrolide (Multidrug)-Resistant Rhodococcus equi.

Authors:  Erdal Erol; Mariela Scortti; Jordan Fortner; Mukesh Patel; José A Vázquez-Boland
Journal:  J Clin Microbiol       Date:  2021-07-28       Impact factor: 5.948
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.